Krsnaa Diagnostics Stock Screener | Share Price & Fundamental Analysis

KRSNAA Healthcare Service Provider
Share Price NSE
₹568.90
▲ 2.65 (0.47%)
2026-04-07 00:00:00
Share Price BSE
₹569.60
▲ 4.30 (0.76%)
2026-04-07 00:00:00
Track Krsnaa Diagnostics share price live with TickJournal's free stock screener. Analyze Krsnaa Diagnostics share price history trends and compare 52-week high low levels. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Krsnaa Diagnostics Market Cap ₹1,785.59 Cr.
KRSNAA P/E Ratio (TTM) 22.66
Krsnaa Diagnostics P/B Ratio 1.97
EPS (TTM) ₹23.04
Dividend Yield 0.49%
Debt to Equity 0.21
KRSNAA 52 Week High ₹869.90
Krsnaa Diagnostics 52 Week Low ₹520.30
Operating Margin 26.00%
Profit Margin 8.11%
KRSNAA Revenue (TTM) ₹185.00
EBITDA ₹50.00
Net Income ₹15.00
Total Assets ₹1,282.00
Total Equity ₹883.00

Krsnaa Diagnostics Share Price History - Stock Screener Chart

Screen KRSNAA historical share price movements with interactive charts. Analyze price trends and patterns.

Krsnaa Diagnostics Company Profile - Fundamental Screener

Screen Krsnaa Diagnostics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KRSNAA shares.
Sector Healthcare Services
Industry Healthcare Service Provider
Sub-Sector Healthcare Service Provider
Segment E
ISIN INE08LI01020

Krsnaa Diagnostics Balance Sheet Screener

Screen KRSNAA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022
Assets
Total Assets 1,282 1,172 910 876
Current Assets 415 421 223 334
Fixed Assets 670 647 471 386
Liabilities
Total Liabilities 0 0 0 0
Current Liabilities 93 81 72 71
Non-Current Liabilities 0 0 0 0
Shareholders' Equity
Total Equity 883 810 739 684
Share Capital 16 16 16 16
Reserves & Surplus 867 794 723 669

Krsnaa Diagnostics Income Statement Screener - Profit & Revenue Analysis

Screen Krsnaa Diagnostics income statement and profit fundamentals. Analyze KRSNAA quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Krsnaa Diagnostics share price evaluation.
Item 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec 2022-Sept 2022-Jun
Revenue 185 210 197 191 184 191 178 171 162 160 144 139 123 127 118
Expenses 135 147 142 133 129 137 128 123 121 124 108 99 89 92 85
EBITDA 50 63 55 57 54 54 50 48 42 36 36 40 34 35 32
Operating Profit % 26.00% 29.00% 27.00% 28.00% 26.00% 27.00% 25.00% 26.00% 24.00% 20.00% 22.00% 26.00% 25.00% 25.00% 25.00%
Depreciation 23 24 22 22 23 22 22 18 21 20 16 15 14 13 12
Interest 8 8 6 7 6 6 5 7 4 3 2 2 2 2 1
Profit Before Tax 20 32 27 29 26 25 23 23 16 13 18 24 18 20 19
Tax 4 8 7 8 6 6 5 4 3 3 3 5 4 5 5
Net Profit 15 24 21 21 19 20 18 19 13 11 15 19 14 15 14
EPS 4.72 7.38 6.35 6.40 6.01 6.07 5.55 5.80 4.09 3.35 4.66 6.03 4.35 5.73 4.53

Krsnaa Diagnostics Cash Flow Screener - Liquidity Fundamentals

Screen KRSNAA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2024-March 2023-March 2022-March 2017-March 2016-March
Operating Activities 24 76 128 64 -23
Investing Activities -129 -109 -241 -54 -47
Financing Activities 84 -33 176 -41 105
Net Cash Flow -20 -66 64 -31 36

Krsnaa Diagnostics Shareholding Pattern Screener

See Krsnaa Diagnostics shareholding pattern with promoter, FII, and DII holdings. Check Krsnaa Diagnostics promoter holding and ownership changes for KRSNAA on TickJournal.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec
Promoter Holding 27.24% 27.11% 27.11% 27.11% 27.03% 27.17% 27.17% 27.24%
FII Holding 3.55% 3.40% 3.67% 4.17% 3.34% 3.33% 3.63% 4.04%
DII Holding 14.26% 14.24% 14.96% 13.86% 15.37% 15.26% 15.86% 14.46%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 29.13% 28.95% 27.40% 27.84% 27.72% 28.73% 28.41% 29.11%
Other Holding 25.81% 26.30% 26.86% 27.01% 26.54% 25.51% 24.94% 25.16%
Shareholder Count 53,559 54,262 52,117 52,380 56,458 55,914 53,519 52,799

Krsnaa Diagnostics Share Dividend Screener - Share Yield Analysis

Check Krsnaa Diagnostics dividend history with payout and yield data. View Krsnaa Diagnostics dividend details including ex-dates and amounts for KRSNAA stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹2.75 0.53%
2024-March ₹2.50 0.32%
2023-March ₹2.75 0.45%
2022-March ₹2.50 0.56%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Krsnaa Diagnostics Stock Index Membership

See which indices include Krsnaa Diagnostics stock. Check KRSNAA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP

Krsnaa Diagnostics Market Events Screener - Corporate Actions

Get Krsnaa Diagnostics corporate actions including splits, bonuses, and buybacks. Check Krsnaa Diagnostics stock events that may affect KRSNAA share price.
Announcement Date Record Date Event Type Information Price Impact
Dividend ₹ 2.75 /share 19.09%
Dividend ₹ 2.75 /share 29.48%
Dividend ₹ 2.50 /share 30.88%
Annual General Meeting NA 34.63%
Dividend ₹ 2.50 /share -2.35%
Annual General Meeting NA -2.52%
2026-02-05 2026-02-05 Quarterly Result Announcement NA 2.22%
2025-11-07 2025-11-07 Quarterly Result Announcement NA -5.58%
2025-08-11 2025-08-11 Quarterly Result Announcement NA 1.65%
2025-05-12 2025-05-12 Quarterly Result Announcement NA -0.88%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -3.27%
2024-10-25 2024-10-25 Quarterly Result Announcement NA -3.06%

Krsnaa Diagnostics Competitors Screener - Peer Comparison

Screen KRSNAA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Dr. Lal Path Labs 22,263 41.48 2,555 11.28% 492 43.78
Vijaya Diagnostic Centre 9,230 56.85 700 23.06% 144 40.76
Metropolis Healthcare 8,744 51.87 1,346 10.64% 146 32.04
Thyrocare Technologies 5,825 42.36 702 20.80% 91 45.58
Nephrocare Health Services 5,304 74.42 770 33.97% 67 47.46
Krsnaa Diagnostics 1,786 22.66 743 16.70% 78 36.51
Suraksha Diagnostic 1,276 39.24 256 15.11% 31 41.69
3B BlackBio DX 1,076 17.03 112 28.72% 48 46.16
One Global Service Provider 1,059 15.97 148 134.60% 19 44.50
Sastasundar Ventures 864 29.21 1,171 -18.47% -134 44.69

Krsnaa Diagnostics Company Announcements - News Screener

Screen KRSNAA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-03-31 Announcement under Regulation 30 (LODR)-Change in Management -
2026-03-24 Closure of Trading Window -
2026-03-17 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-03-16 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot -
2026-02-26 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-02-23 Announcement under Regulation 30 (LODR)-Allotment -
2026-02-22 Announcement under Regulation 30 (LODR)-Change in Directorate -
2026-02-22 Update Of Meeting Held On February 22 2026. -
2026-02-11 Announcement under Regulation 30 (LODR)-Earnings Call Transcript -
2026-02-10 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-02-06 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome -
2026-02-05 Announcement under Regulation 30 (LODR)-Investor Presentation -
2026-02-05 List Of The Key Managerial PersonnelS (Kmps) For The Purpose Of Determining The Materiality Of An Event Or Information & Making Disclosures To The Stock Exchange(S). -
2026-02-05 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-02-05 Quarter And Nine Months Ended December 31 2025. -
2026-02-05 Board Meeting Outcome for Meeting Held On February 05 2026. -
2026-01-30 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-01-30 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation -
2026-01-28 Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025. -